207 related articles for article (PubMed ID: 23429262)
41. miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
Zhu X; Ma SP; Yang D; Liu Y; Wang YP; Lin T; Li YX; Yang SH; Zhang WC; Wang XL
Cell Physiol Biochem; 2018; 51(4):1969-1981. PubMed ID: 30513513
[TBL] [Abstract][Full Text] [Related]
42. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
44. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
45. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
46. Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
Lin Y; Wu J; Chen H; Mao Y; Liu Y; Mao Q; Yang K; Zheng X; Xie L
FEBS Lett; 2012 Feb; 586(4):442-7. PubMed ID: 22289176
[TBL] [Abstract][Full Text] [Related]
47. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes.
Liu Q; Fu H; Sun F; Zhang H; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
Nucleic Acids Res; 2008 Sep; 36(16):5391-404. PubMed ID: 18701644
[TBL] [Abstract][Full Text] [Related]
48. Simvastatin induces G
Chen MJ; Cheng AC; Lee MF; Hsu YC
J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
[TBL] [Abstract][Full Text] [Related]
49. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
50. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
51. The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
Zhang Y; Qu D; Morris EJ; O'Hare MJ; Callaghan SM; Slack RS; Geller HM; Park DS
J Neurosci; 2006 Aug; 26(34):8819-28. PubMed ID: 16928871
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
53. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
55. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
56. 3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation.
Jin Y
Mol Cell Biochem; 2011 Dec; 358(1-2):345-54. PubMed ID: 21761201
[TBL] [Abstract][Full Text] [Related]
57. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
Gumina MR; Xu C; Chiles TC
Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
[TBL] [Abstract][Full Text] [Related]
58. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
[TBL] [Abstract][Full Text] [Related]
59. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
Xing Z; Zhang Y; Zhang X; Yang Y; Ma Y; Pang D
Phytother Res; 2013 Dec; 27(12):1790-4. PubMed ID: 23401195
[TBL] [Abstract][Full Text] [Related]
60. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
